{
  "actions": [
    {
      "acted_at": "2020-01-09",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2020-01-09",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3180-116",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "116",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-01-09",
  "number": "3180",
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr2452-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "hr4106-116",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "Responsibility in Drug Advertising Act of 2020",
  "sponsor": {
    "bioguide_id": "K000383",
    "district": null,
    "name": "King, Angus S., Jr.",
    "state": "ME",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-01-09",
  "subjects": [
    "Drug safety, medical device, and laboratory regulation",
    "Health",
    "Marketing and advertising",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2020-01-09",
    "date": "2021-09-03T18:30:14Z",
    "text": "Responsibility in Drug Advertising Act of 2020\n\nThis bill prohibits direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Responsibility in Drug Advertising Act of 2020",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Responsibility in Drug Advertising Act of 2020",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.",
      "type": "official"
    }
  ],
  "updated_at": "2022-02-08T23:15:31Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s3180.xml"
}